Search

What milestones will define the next era in the mRNA story?

Welcome to our Special Series E-book on Advanced Medicine!

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.

Your product defines the process, and your process defines the equipment requirements.

Biopharmaceutical development is in need of a speed boost. Multi-omics could be the answer.

Is autologous cell therapy a realistic proposition for solid tumors?

Inhalers still don’t work as well as they should, but computational modeling is here to help.